Skip to main content

Advertisement

Fig. 6 | Clinical and Molecular Allergy

Fig. 6

From: Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy

Fig. 6

Cytokine concentrations after ex vivo stimulation of spleen-derived lymphocytes with PE, determined by ELISA. Spleen-derived lymphocytes from day 78 were cultured for 96 h in the presence of PE or medium (treatment protocol 2, Fig. 1, medium data not shown). a IL-5 concentration. b IL-13 concentration. c IL-10 concentration. d IFN-γ concentration. Data are represented as mean ± SEM n = 6–8 mice/group. Statistical analysis was performed using Kruskal–Wallis test with Dunn’s post hoc test. **P < 0.01 compared to PE-sensitized control. ^P < 0.05 compared to scFOS/lcFOS control. IT, immunotherapy; s.c., subcutaneous; PE, peanut extract; IL-, interleukin; FF, scFOS/lcFOS

Back to article page